Browsing Tag

Akero Therapeutics

Akero Presents New Analysis of Phase 2a BALANCED Study Data Showing Additional Qualitative Evidence…

James Pereira Nov 12, 2021

Most EFX-treated patients with end-of-treatment biopsies showed improvements in features of steatohepatitis (35 of 40;…
Read More...

Study Published in Nature Medicine Shows Investigational NASH Drug Reduced Liver Fat to Normal…

James Pereira Jul 8, 2021

SOUTH SAN FRANCISCO, Calif., July 08, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a…
Read More...

Akero Therapeutics Presents at the American Diabetes Association’s 81st Scientific Sessions,…

James Pereira Jun 26, 2021

SOUTH SAN FRANCISCO, Calif., June 25, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a…
Read More...